Tovorafenib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Access in all areas? A round-up of developments in market access and health technology assessment: first Joint Clinical Assessment report released.
Journal: Journal of comparative effectiveness research
Published: June 17, 2026
Class-level DILI saturation and hERG-driven risk stratification among 2024-2025 FDA-approved kinase inhibitors: an in silico multi-platform safety analysis.
Journal: Investigational new drugs
Published: March 16, 2026
Rebound regrowth phenomenon in patients with pediatric low-grade gliomas treated with MAPK inhibitors - a systematic review.
Journal: Oncology reviews
Published: February 23, 2026
Clinical experience with tovorafenib in adults with treatment-refractory high- and low-grade gliomas.
Journal: Neuro-oncology practice
Published: December 29, 2025
Emerging Targeted Therapies and Ongoing Clinical Trials in Pediatric Brain Tumors
Journal: No shinkei geka. Neurological surgery
Published: December 09, 2025
Rare gliomas: standard treatment approaches and new target therapies.
Journal: Current opinion in neurology
Published: September 24, 2025
Molecular convergence enables precision medicine for pediatric low grade gliomas.
Journal: Discover oncology
Published: August 29, 2025
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications.
Journal: Current therapeutic research, clinical and experimental
Published: August 07, 2025
The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective.
Journal: Neuro-oncology
Published: July 22, 2025
New and Emerging Therapies for Patients with Low-Grade Glioma.
Journal: CNS drugs
Published: June 06, 2025
Last Updated: 06/30/2026